Southpoint Capital Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,263,889
Closed -$59.2M 50
2024
Q3
$59.2M Sell
1,263,889
-680,555
-35% -$31M 1.4% 29
2024
Q2
$82.2M Sell
1,944,444
-388,889
-17% -$17.1M 2.04% 20
2024
Q1
$103M Buy
2,333,333
+447,222
+24% +$20.4M 2.04% 20
2023
Q4
$86.9M Buy
1,886,111
+471,528
+33% +$20.1M 1.87% 22
2023
Q3
$60.8M Buy
1,414,583
+471,527
+50% +$22M 1.36% 25
2023
Q2
$45M Buy
+943,056
New +$45.5M 0.98% 32

Other funds holding QGEN

Southpoint Capital Advisors's QGEN Position: Q4 2024 in Review

Southpoint Capital Advisors sold out of Qiagen (QGEN) in Q4 2024, closing a stake of 1,263,889 shares — an estimated $59.2M sold.

Southpoint Capital Advisors first reported a position in QGEN in Q2 2023 and held it in 6 quarters. The position peaked at $103M in Q1 2024. 324 funds tracked by Wall St. Rank hold QGEN as of Q4 2024.

  • Southpoint Capital Advisors reported no remaining Qiagen position as of Q4 2024 after selling out during the quarter.
  • Southpoint Capital Advisors sold 1,263,889 Qiagen shares in Q4 2024, an estimated $59.2M.
  • Southpoint Capital Advisors first reported a position in Qiagen in Q2 2023 and held it in 6 quarters.
  • Southpoint Capital Advisors's Qiagen position peaked at $103M in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Qiagen as of Q4 2024.

Based on Southpoint Capital Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.